Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capravirine + ART in Treatment-Naive HIV
NCT00004998Phase 2Suspended
- Sponsor
- Agouron Pharmaceuticals
- Start
- Nov 1999
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, open-label trial of capravirine in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Agouron Pharmaceuticals. Started Nov 1999; status: suspended.
02
Drugs
capravirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00004998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004998.